Articles Published in 2007

AstraZeneca to Work with Keio University in Japan

Wednesday, October 3, 2007 11:08 AM

AstraZeneca’s Japanese subsidiary, AstraZeneca KK, signed a Master Clinical Study Agreement with Keio University School of Medicine based in Tokyo. The university reported that due to Japan’s slow pace of drug research, it has taken steps to build up its own clinical trial capabilities and improve the efficiency of its research.

More... »


PRA Moves Headquarters To North Carolina

Monday, October 1, 2007 07:23 AM

PRA International plans to relocate its corporate headquarters from Reston, Va., to Raleigh, N.C. by the end of 2007. The move is to facilitate the CRO’s plans to grow the business. Presently only 37 employees are expected to be affected.

More... »


HHS Report Criticizes FDA’s Human Subject Protection Efforts and Lack of Site Audits

Friday, September 28, 2007 02:32 PM

The U.S. Food and Drug Administration (FDA) audited fewer than 1% of investigative sites, the inspector general of the Department of Health and Human Services (HHS), Daniel R. Levinson, found in a report released Friday.

More... »

Top Stories for the Week of Sept. 24th 2007

Friday, September 28, 2007 11:55 AM

Top News

More... »

Promising Results Seen in Lung Cancer Trials

Wednesday, September 26, 2007 03:20 PM

Merck KGaA reported positive long-term results from a phase II trial of Stimuvax for the treatment of non-small cell lung cancer (NSCLC). The drug is a MUC-1 peptide-based liposomal vaccine, for the potential  treatment of cancers.

More... »

Congress Passes Long Awaited PDUFA Renewal Act

Monday, September 24, 2007 11:27 AM

The U.S. House and Senate passed the long awaited FDA Revitalization Act, a five-year renewal of the Prescription Drug User Fee Act of 1992 (PDUFA). PDUFA allows the FDA to collect fees from drug and device companies applying for regulatory approval. That law was set to expire on Sept. 30.

More... »

Top Stories for the Week of Sept. 17th 2007

Friday, September 21, 2007 07:53 AM

Top News

More... »

Synergy Creates Alliance With Indian CRO Neeman Medical

Tuesday, September 18, 2007 06:40 AM

Russian CRO Synergy Research Group (SynRG) has made its next move to create a global CRO alliance, forming a partnership with Neeman Medical International, an India-based CRO. The alliance will focus on providing international sponsors with monitoring and site and data management services. Neeman Medical was founded in 2001 and is headquartered in New Delhi.

More... »

CenterWatch Monthly: September 2007 Issue

Monday, September 17, 2007 11:36 AM

Fraudulent Study Broker At-Large: Cherie Thibodeau

More... »

ARISE Trials Shows Promising Results for Diabetes

Monday, September 17, 2007 07:41 AM

Atherogenics reported positive results from a phase III trial of succinobucol (AGI-1067), an antioxidant oral vascular cell adhesion molecule-1 (VCAM-1) gene expression inhibitor, for the treatment of diabetes and coronary heart disease. This trial, dubbed ARISE (Aggressive Reduction of Inflammation Stops Events), enrolled over 6,000 subjects internationally. Results were reported at the European Society of Cardiology Congress 2007.

More... »

`

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs